Genetics of Proteus Syndrome Treatment & Management

  • Author: Beth A Pletcher, MD; Chief Editor: Bruce Buehler, MD   more...
 
Updated: Mar 18, 2010
 

Medical Care

The mainstays of treatment for Proteus syndrome include early identification of serious medical problems and the use of prophylactic and symptomatic treatment.

  • Hemihyperplasia
    • Medical approaches are limited and should be considered in the context of functional improvement.
    • Leg length discrepancy can create a host of secondary morbidities and needs to be addressed by an experienced orthopedist.
    • Macrodactyly can make it difficult for the patient to write, hold objects, dress, eat, or find comfortable footwear.
  • Hemifacial macrosomia or macroglossia
    • These present cosmetic concerns and may affect dental occlusion and mastication.
    • Augment routine dental and orthodontic care with a maxillofacial surgeon or craniofacial team consultation as indicated.
  • Scoliosis: Early recognition may permit nonsurgical attempts to halt progression.
  • Cutaneous and subcutaneous lesions: Periodic evaluation is essential since lipomas and vascular malformations may have local or even systemic effects.
  • Cutaneous vascular markings and malformations: Laser treatment is useful for removing cutaneous vascular markings and malformations, such as port wine stains and capillary hemangiomas. It is not yet effective for permanently removing café au lait spots or melanin-related hyperpigmentation.
  • Although consistently successful way to treat epidermal nevi has been established, individual reports have noted success with various approaches such as CO 2 or ruby lasers, dermatome excision followed by phenol peel, cryotherapy, keratolytics, and even intralesional steroid injection.[14]
  • Secondary thrombocytopenia: This may be indicated by a history of easy bruising or presence of petechiae.
  • Thrombosis: Aggressive management of thrombosis may be lifesaving in patients who present with calf or leg pain, a palpable cord, and shortness of breath or respiratory distress. Physicians who care for individuals with Proteus syndrome should be made aware of the potential thrombotic risks; hematologic evaluation prior to elective surgery should also be considered.[3]
  • Internal lesions: MRIs of the chest and abdomen can reveal internal lesions such as lipomas or pulmonary cysts. Undetected, these can cause very serious problems before becoming symptomatic.
Next

Surgical Care

  • Preoperative coagulation studies may provide guidance for perioperative and postoperative management of patients with Proteus syndrome. Some clinicians have suggested serious consideration of prophylactic anticoagulation prior to elective surgery; however, this decision must be made on an individual basis while exploring the risks and benefits and in the context of the patient’s clinical circumstances (including laboratory studies and the anticipated surgery).[9]
  • Progressive scoliosis may require orthopedic intervention.
  • Exceptionally large digits may require surgical reduction or even amputation in extreme circumstances so that the patient can wear shoes or use their hand.
  • Hemifacial macrosomia or macroglossia may require surgical intervention if airway obstruction, feeding difficulties, or severe malocclusion is present. These complex situations often require a coordinated, multidisciplinary team approach with input from a craniofacial surgeon, orthodontist, and dentist.
  • Although any competent surgeon can resect large or invasive cutaneous or subcutaneous lesions, plastic surgical consultation is advisable for cosmetically important areas such as the face. Subcutaneous lesions impinging on vital structures, obstructing vision, or growing rapidly deserve immediate attention. Laser lipolysis using a 980-nm laser diode is a more recent addition to the treatment armamentarium and has been used successfully in a child to reduce the size of a large lipomatous lesion.[15] This approach may be shown in the future to have advantages over surgical excision or liposuction for specific types of lesions.
  • Internal lipomas or cystic lung malformations may also require surgical resection.
Previous
Next

Consultations

  • An orthopedist is a vital team member who must address the functional significance of both hemihyperplasia and scoliosis.
  • A craniofacial surgeon or surgical team can address cranial asymmetry or hemifacial macrosomia.
  • A general or plastic surgeon can address resection of cutaneous or subcutaneous lesions when necessary.
  • A neurosurgeon can address CNS lesions such as cortical overgrowth, with or without hydrocephalus. Patients undergoing complex craniofacial procedures can also benefit from a neurosurgeon's operative expertise.
  • A dermatologist can evaluate and monitor subcutaneous and cutaneous lesions and can perform biopsies when necessary.
  • An ophthalmologist can closely monitor strabismus or orbital asymmetry in a patient with ocular involvement.
  • A dentist can address dental anomalies and an orthodontist can treat malocclusion.
  • A geneticist and genetic counselor can provide the patient and family with additional information about the diagnosis, diagnostic testing, proposed genetic mechanisms, and recurrence risks. Family planning options and prenatal diagnosis are also addressed in this clinical setting.
  • A developmental pediatrician can evaluate a child with learning disabilities or developmental delays. This specialist makes recommendations for ongoing therapy and school interventions.
  • A psychologist or trained mental health professional can assist a child or adolescent with significant disfigurement, if adjustment problems arise. Social stigmatization is a major obstacle for many children and adults. Both patients and family members may benefit from ongoing psychotherapy. Clinicians should be especially aware of how parents of affected children are coping and should consider referral for psychological support as needed. Peer support for affected older teens and adults is available from the Proteus Syndrome Organization.[16]
Previous
Next

Activity

  • In the absence of surgery, encourage patients to participate in all activities as fully as possible.
  • Patients who undergo spinal fusion or other major surgical procedures need to confer with their surgeons about acceptable activities.
Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Beth A Pletcher, MD  Associate Professor, Co-Director of The Neurofibromatosis Center of New Jersey, Department of Pediatrics, University of Medicine and Dentistry of New Jersey

Beth A Pletcher, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Medical Genetics, American Medical Association, and American Society of Human Genetics

Disclosure: Nothing to disclose.

Specialty Editor Board

Elaine H Zackai, MD  Professor of Pediatrics, Professor of Obstetrics and Gynecology, Professor of Pediatrics in Human Genetics, University of Pennsylvania School of Medicine; Director, Clinical Genetics Center, University of Pennsylvania; Senior Physician and Director of Clinical Genetics, The Children's Hospital of Philadelphia

Elaine H Zackai, MD is a member of the following medical societies: American Cleft Palate/Craniofacial Association, American College of Medical Genetics, and American Society of Human Genetics

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Pharmacy Editor, eMedicine

Disclosure: Nothing to disclose.

Robert Anthony Saul, MD  Clinical Professor, Department of Pediatrics, University of South Carolina; Senior Clinical Geneticist, Greenwood Genetic Center

Robert Anthony Saul, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Medical Genetics, and American College of Physician Executives

Disclosure: Nothing to disclose.

Daniel Rauch, MD, FAAP  Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine

Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine

Disclosure: Baxter Honoraria Consulting

Chief Editor

Bruce Buehler, MD  Professor, Department of Pediatrics and Genetics, Director RSA, University of Nebraska Medical Center

Bruce Buehler, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Pediatrics, American Association on Mental Retardation, American College of Medical Genetics, American College of Physician Executives, American Medical Association, and Nebraska Medical Association

Disclosure: Nothing to disclose.

References
  1. Cohen MM Jr. "Proteus syndrome". In: Cohen MM Jr., Neri G, Weksberg R eds. Overgrowth Syndromes, Chapter 9. 170(6 Pt 1). New York: Oxford University Press; 2002:pp75-110.

  2. Brockmann K, Happle R, Oeffner F, König A. Monozygotic twins discordant for Proteus syndrome. Am J Med Genet A. Aug 15 2008;146A(16):2122-5. [Medline].

  3. Cohen MM Jr. Proteus syndrome: an update. Am J Med Genet C Semin Med Genet. Aug 15 2005;137C(1):38-52. [Medline].

  4. Turner JT, Cohen MM Jr, Biesecker LG. Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases. Am J Med Genet A. Oct 1 2004;130A(2):111-22. [Medline].

  5. Pazzaglia UE, Beluffi G, Bonaspetti G, et al. Bone malformations in Proteus syndrome: an analysis of bone structural changes and their evolution during growth. Pediatr Radiol. Aug 2007;37(8):829-35. [Medline].

  6. Happle R. Lipomatosis and partial lipohypoplasia in Proteus syndrome: a clinical clue for twin spotting?. Am J Med Genet. Apr 10 1995;56(3):332-3. [Medline].

  7. Asahina A, Fujita H, Omori T, Kai H, Yamamoto M, Mii K. Proteus syndrome complicated by multiple spinal meningiomas. Clin Exp Dermatol. Nov 2008;33(6):729-32. [Medline].

  8. Furquim I, Honjo R, Bae R, Andrade W, Santos M, Tannuri U. Proteus syndrome: report of a case with recurrent abdominal lipomatosis. J Pediatr Surg. Apr 2009;44(4):E1-3. [Medline].

  9. Biesecker L. The challenges of Proteus syndrome: diagnosis and management. Eur J Hum Genet. Nov 2006;14(11):1151-7. [Medline].

  10. Bastos H, da Silva PF, de Albuquerque MA, Mattos A, Riesgo RS, Ohlweiler L. Proteus syndrome associated with hemimegalencephaly and Ohtahara syndrome: report of two cases. Seizure. Jun 2008;17(4):378-82. [Medline].

  11. Elsayes KM, Menias CO, Dillman JR, et al. Vascular malformation and hemangiomatosis syndromes: spectrum of imaging manifestations. AJR Am J Roentgenol. May 2008;190(5):1291-9. [Medline].

  12. Irion KL, Hocchegger B, Marchiori E, et al. Proteus syndrome: high-resolution CT and CT pulmonary densitovolumetry findings. J Thorac Imaging. Feb 2009;24(1):45-8. [Medline].

  13. Hoey SE, Eastwood D, Monsell F, Kangesu L, Harper JI, Sebire NJ. Histopathological features of Proteus syndrome. Clin Exp Dermatol. May 2008;33(3):234-8. [Medline].

  14. Sugarman JL. Epidermal nevus syndromes. Semin Cutan Med Surg. Dec 2007;26(4):221-30. [Medline].

  15. Buis J, Enjolras O, Soupre V, Roman S, Vazquez MP, Picard A. 980-nm laser diode and treatment of subcutaneous mass in Proteus-like syndrome. J Eur Acad Dermatol Venereol. Jan 2010;24(1):109-11. [Medline].

  16. Turner J, Biesecker B, Leib J, et al. Parenting children with Proteus syndrome: experiences with, and adaptation to, courtesy stigma. Am J Med Genet A. Sep 15 2007;143A(18):2089-97. [Medline].

  17. Biesecker LG, Happle R, Mulliken JB, et al. Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet. Jun 11 1999;84(5):389-95. [Medline].

  18. Becktor KB, Becktor JP, Karnes PS, Keller EE. Craniofacial and dental manifestations of Proteus syndrome: a case report. Cleft Palate Craniofac J. Mar 2002;39(2):233-45. [Medline].

  19. Biesecker LG, Peters KF, Darling TN, et al. Clinical differentiation between Proteus syndrome and hemihyperplasia: description of a distinct form of hemihyperplasia. Am J Med Genet. Oct 2 1998;79(4):311-8. [Medline].

  20. Cohen MM Jr. Further diagnostic thoughts about the Elephant Man. Am J Med Genet. Apr 1988;29(4):777-82. [Medline].

  21. Cohen MM Jr. Mental deficiency, alterations in performance, and CNS abnormalities in overgrowth syndromes. Am J Med Genet C Semin Med Genet. Feb 15 2003;117C(1):49-56. [Medline].

  22. Franc-Guimond J, Houle AM, Barrieras D. The Proteus syndrome associated with life threatening hematuria. J Urol. Dec 2003;170(6 Pt 1):2418-9. [Medline].

  23. Goodship J, Redfearn A, Milligan D, et al. Transmission of Proteus syndrome from father to son?. J Med Genet. Nov 1991;28(11):781-5. [Medline].

  24. Hamm H. Cutaneous mosaicism of lethal mutations. Am J Med Genet. Aug 6 1999;85(4):342-5. [Medline].

  25. Happle R. Elattoproteus syndrome: delineation of an inverse form of Proteus syndrome. Am J Med Genet. May 7 1999;84(1):25-8. [Medline].

  26. Happle R. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol. Apr 1987;16(4):899-906. [Medline].

  27. Hoeger PH, Martinez A, Maerker J, et al. Vascular anomalies in Proteus syndrome. Clin Exp Dermatol. May 2004;29(3):222-30. [Medline].

  28. Krüger G, Pelz L, Wiedemann HR. Transmission of Proteus syndrome from mother to son?. Am J Med Genet. Jan 1 1993;45(1):117-8. [Medline].

  29. Nazzaro V, Cambiaghi S, Montagnani A, et al. Proteus syndrome. Ultrastructural study of linear verrucous and depigmented nevi. J Am Acad Dermatol. Aug 1991;25(2 Pt 2):377-83. [Medline].

  30. Nguyen D, Turner JT, Olsen C, et al. Cutaneous manifestations of proteus syndrome: correlations with general clinical severity. Arch Dermatol. Aug 2004;140(8):947-53. [Medline].

  31. Plötz SG, Abeck D, Plotz W, et al. Proteus syndrome with widespread portwine stain naevus. Br J Dermatol. Dec 1998;139(6):1060-3. [Medline].

  32. Sigaudy S, Fredouille C, Gambarelli D, et al. Prenatal ultrasonographic findings in Proteus syndrome. Prenat Diagn. Oct 1998;18(10):1091-4. [Medline].

  33. Twede JV, Turner JT, Biesecker LG, et al. Evolution of skin lesions in Proteus syndrome. J Am Acad Dermatol. May 2005;52(5):834-8. [Medline].

  34. Wiedemann HR, Burgio GR, Aldenhoff P, et al. The proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies and possible accelerated growth and visceral affections. Eur J Pediatr. Mar 1983;140(1):5-12. [Medline].

Previous
Next
 
Macroglossia and hemifacial overgrowth associated with hyperpigmentation.
Port wine stain on the trunk with small epidermal nevus.
Macrodactyly with splaying of toes after toe reduction procedure.
Ear enlargement associated with cutaneous hyperpigmentation and hemifacial macrosomia.
Scoliosis with scar resulting from prior surgical resection of a large subcutaneous lipoma.
Evidence of proximal muscle wasting of the upper extremities.
Hypertrophy of the thighs and calves.
Profile demonstrating retrognathia.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.